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Although the pathogenesis of intestinal metaplasia remains
unknown1, it is well recognized that chronic gastritis and in-
testinal metaplasia are precursor conditions of gastric can-
cer. In intestinal metaplasia, the original gastric mucosa is re-
placed by glandular structures bearing an intestinal phenotype.
Intestinal metaplasia is one of several steps in the prolonged
precancerous process of gastric cancer, mostly of the intes-
tinal histological type. There are 2 other types of intestinal
metaplasia: the complite (tpe I) and the incomplite (tpe III)
type. The incomplite type is more frequently associated with
dysplasia and early carcinoma and is considered a more ad-
vanced stage of the process or of higher malignant poten-
tial2.
On the other hand, there is enough evidence about the
causal relationship between smoking and gastric cancer risk3.
The study by Peleteiro and colleagues deals with a systematic
review of prevalence of intestinal metaplasia among Helico-
bacter pylori infected individuals and the correlation with na-
tional tobacco availability by means of an ecological ana-
lysis4.
Several case-control studies have shown the association
between intestinal metaplasia and smoking. Although an eco-
logical study is not the best appropiate epidemiological design
to support the hypothesis of the role of smoking in the risk of
intestinal metaplasia or in the progression from intestinal me-
taplasia to gastric cancer, there are no reviews published on
the prevalence of intestinal metaplasia. This study provides
a large, detailed, and useful information about the prevalen-
ce of intestinal metaplasia in 29 countries of five continents.
Nevertheless, caution should be taken when the prevalence
of intestinal metaplasia between studies and countries. The
population source (clinical- or population-based), the age and
the sex of participants, as well as the number of biopsies spe-
cimens, and the biopsy site, may influence the prevalence of
intestinal metaplasia and therefore the comparability of results
from different studies.
Information of tobacco availability in each country, expres-
sed as the adult apparent tobacco consumption in cigarettes
per day, were obtained from the Tobacco and Health Report of
the WHO or from the National Tobacco Information Online Sys-
tem database, which provide realiable information at the po-
pulation level. Despite the importance of these results, it is ne-
cessary to stress that causal relationships can be only derived
from individual exposure data from studies to come.
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